Medical device company Oventus Medical (ASX: OVN) has confirmed its sleep treatment platform will be included in a range of obstructive sleep apnoea (OSA) treatment solutions being sold by Aeroflow ...
The global sleep apnea diagnostic systems market, currently valued at US$ 4.81 billion in 2023, is projected to grow at a robust CAGR of 6.8%, reaching US$ 9.27 billion by 2033. This growth is driven ...
Please provide your email address to receive an email when new articles are posted on . Researchers assessed an expiratory positive airway pressure enhanced mandibular advancement device (EMAD) ...
The Global Sleep Apnea Devices Industry is experiencing a period of exceptional growth, exhibiting resilience and sustained market demand according to a recent market analysis. This trend is projected ...
The global Sleep Apnea Devices Industry is poised for remarkable growth, with a steady compound annual growth rate (CAGR) of 9.5% projected during the forecast period. According to the latest market ...
The Sleep Apnea Devices Market is set to thrive at a steady CAGR of 9.5% during the forecast period. The market holds a share of US$ 8.2 billion in 2023 while it is anticipated to cross a value of US$ ...
WILMINGTON, DE / ACCESSWIRE / April 17, 2023 / Wilmington, Delaware, United States, Transparency Market Research Inc. - According to research, the global sleep apnea devices market is expected to grow ...
BRISBANE, Australia – Oventus Medical has reapplied to Palmetto GBA, the pricing data analysis and coding contractor (PDAC), for approval of the newly submitted Optima version of its O2Vent oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback